CClinicalTrials.gg
CompletedNCT04097249Updated Sep 20, 2019

Infrared Thermography for the Diagnosis of Musculoskeletal Pain

An observational study in Healthy, Pain and Temperature Change, Body, sponsored by Universidad San Jorge. Completed. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-20.

Sponsored by Universidad San Jorge · Observational

Study type
Observational
Model
Case-crossover
Time perspective
Cross-sectional
Enrollment
20
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study sought to evaluate the vasomotor response in the pain referral area of healthy individuals, performing the same procedure with and without the experience of delayed onset muscle soreness.

Read the detailed description

Validity of infrared thermography for properly diagnosing musculoskeletal pain and their clinical applicability is lacking. This study investigates temperature changes on the upper extremity before and after a suprathreshold stimulation (painful stimulus) with a digital algometer over the infraspinatus muscle. The same procedure is performed in two consecutive days, 24 hours apart (Day-1 and Day-2). At the end of Day-1, an eccentric exercise is performed in order to to induce delayed onset muscle soreness on the external rotators of the shoulder.

02

Conditions studied

  • Healthy
  • Pain
  • Temperature Change, Body

Keywords

  • Musculoskeletal pain
  • Delayed Onset Muscle Soreness
  • Pain sensitivity
  • Infrared thermography
  • Referred pain
03

In context

Musculoskeletal Pain

493 studies on the registry are indexed under Musculoskeletal Pain; 114 are open to participants now.

This study's enrollment of 20 is below the median of 163 across 136 observational studies indexed under Musculoskeletal Pain.

Browse Musculoskeletal Pain studies →

Lead sponsor

Universidad San Jorge is the lead sponsor of 32 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants with no acute pain, chronic pain or other medical disorders relevant to this study.

Inclusion criteria

  • Being healthy and free from any pain specific to the upper limbs and/or in general.

Exclusion criteria

Exclusion Criteria:

  • Previous history of chronic pain.
  • Any systemic diseases or regional pathology which can interfere with the outcome measures.
05

Study design

Observational model
Case-crossover
Time perspective
Cross-sectional
Enrollment
20 participants (actual)
Target follow-up
2 Days
Patient registry
Yes

Groups and cohorts

  • Healthy subjects

    Participants free from any pain specific to the upper limb, chronic pain or other disease.

06

What researchers measure

Primary outcomes

  1. Changes in temperature of pixels on the upper extremity: infrared thermography

    A thermography image of the upper extremity of the body will be taken on both days of assessment before and after applying a painful stimulus. Changes in colour pixels will be analysed to determine temperature changes.

    Time frame: Day-1 (baseline assessment, pre exercise before painful stimulus), Day-1 (baseline assessment, pre exercise after painful stimulus), Day-2 (24 hours post-exercise before painful stimulus), Day-2 (24 hours post-exercise after painful stimulus)

Secondary outcomes

  1. Changes in Pressure Pain Thresholds: pressure algometry

    Changes in pressure pain thresholds will be determined with pressure algometry over the infraspinatus muscle. Pressure Pain Threshold is defined as the exact time point where the pressure is first being perceived as painful.

    Time frame: Day-1 (baseline assessment, pre exercise before painful stimulus), Day-2 (24 hours post-exercise before painful stimulus)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — There are currently no plan on sharing data from this study with other researchers.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 20, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04097249
Lead sponsor
Universidad San Jorge
Responsible party
Sponsor
First posted
Sep 20, 2019
Start date
Oct 1, 2015
Primary completion
Apr 29, 2016
Completion
Apr 30, 2016
Last update
Sep 20, 2019

Study contacts

Pablo Herrero, PhD
study director · Universidad San Jorge

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion